Consistent with their study, we showed that aldo-keto reductases were not only highly expressed in lung cancer but also in HNSCC patients with a dysregulated NRF2 pathway and could be used as biomarkers. Here, NFE2L2 is linked to head and neck squamous cell carcinoma.